[FATE] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
11-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -18.44%
YoY- -69.64%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 58,980 18,414 11,142 2,515 2,632 1,026 1,027 96.36%
PBT -18,881 -65,690 -45,089 -33,520 -19,760 -14,135 -10,126 10.93%
Tax -9,711 -8,777 -1,121 0 1,091 331 111 -
NP -9,170 -56,913 -45,089 -33,520 -19,760 -14,135 -10,126 -1.63%
Tax Rate - - - - - - - -
Total Cost 68,150 75,327 56,231 36,035 22,392 15,161 11,153 35.19%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -15.55 -309.07 -404.68 -1,332.80 -750.76 -1,377.68 -985.98 -49.90%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.09 -0.59 -0.48 -0.44 -0.30 -0.27 -0.24 -15.07%
EPS Diluted -0.09 -0.59 -0.48 -0.44 -0.30 -0.27 -0.24 -15.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.